1. Home
  2. JAGX vs APDN Comparison

JAGX vs APDN Comparison

Compare JAGX & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • APDN
  • Stock Information
  • Founded
  • JAGX 2013
  • APDN 1983
  • Country
  • JAGX United States
  • APDN United States
  • Employees
  • JAGX N/A
  • APDN N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • APDN Other Consumer Services
  • Sector
  • JAGX Health Care
  • APDN Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • APDN Nasdaq
  • Market Cap
  • JAGX 3.4M
  • APDN 2.7M
  • IPO Year
  • JAGX N/A
  • APDN N/A
  • Fundamental
  • Price
  • JAGX $2.35
  • APDN $4.06
  • Analyst Decision
  • JAGX Strong Buy
  • APDN
  • Analyst Count
  • JAGX 1
  • APDN 0
  • Target Price
  • JAGX $60.00
  • APDN N/A
  • AVG Volume (30 Days)
  • JAGX 75.4K
  • APDN 137.8K
  • Earning Date
  • JAGX 08-14-2025
  • APDN 08-19-2025
  • Dividend Yield
  • JAGX N/A
  • APDN N/A
  • EPS Growth
  • JAGX N/A
  • APDN N/A
  • EPS
  • JAGX N/A
  • APDN N/A
  • Revenue
  • JAGX $11,552,000.00
  • APDN $3,790,616.00
  • Revenue This Year
  • JAGX $22.41
  • APDN $57.08
  • Revenue Next Year
  • JAGX $30.00
  • APDN $40.00
  • P/E Ratio
  • JAGX N/A
  • APDN N/A
  • Revenue Growth
  • JAGX 13.93
  • APDN N/A
  • 52 Week Low
  • JAGX $1.93
  • APDN $4.04
  • 52 Week High
  • JAGX $35.25
  • APDN $2,655.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.26
  • APDN 33.11
  • Support Level
  • JAGX $2.02
  • APDN $4.04
  • Resistance Level
  • JAGX $2.33
  • APDN $4.64
  • Average True Range (ATR)
  • JAGX 0.14
  • APDN 0.35
  • MACD
  • JAGX 0.07
  • APDN -0.01
  • Stochastic Oscillator
  • JAGX 58.33
  • APDN 1.04

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: